Rinascera Therapeutics
Boston, US · Founded 2025 · Delaware corporation · 1 known investors
Find your way into Rinascera Therapeutics
287 people in our graph share verified history with the Rinascera Therapeutics team — schools, employers, funds. One of them is your warm intro.
Murat Bicerunlockedknows Max Dawson · together at Babson F.W. Olin Graduate School of Business (overlapped)
×8knows the team · via Babson F.W. Olin Graduate School of Business
×2knows the team · via Merck KGaA, Darmstadt, Germany
knows the team · via DermBiont
Founders & leadership
NE
Nichola EliovitsExecutive
MD
Max DawsoninExecutiveMax Dawson is Chief Operating Officer and Co-Founder of Rinascera Therapeutics, a clinical-stage biotechnology company developing therapies for rare dermatologic diseases. He brings more than 25 years of biotechnology experience, including prior roles as Chief Operating Officer at DermBiont and positions in finance, business development, and operations at companies including Vertex Pharmaceuticals, Merck Serono, Dyax, and Adagene; he holds an MBA from Babson College and an undergraduate degree from Bates College.
KB
Karl BeutnerExecutive
Board
DY
Investors · 1
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 1 round · 2025
▶$2.5MraisedOct 2025 · 3 investors · BiotechnologyRule 506(b)
▶$2.5MraisedOct 2025 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nichola EliovitsExecutive Officer, Director
- Max DawsonExecutive Officer
- Daniel YadegarDirector
- Karl BeutnerExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Rinascera Therapeutics's investors?
- Rinascera Therapeutics's investors include Newpath Partners.
- How much funding has Rinascera Therapeutics raised?
- Rinascera Therapeutics has disclosed $2.5M raised across 1 round.
- Where is Rinascera Therapeutics headquartered?
- Rinascera Therapeutics is headquartered in Boston, US.